In this handout photo shows a new vaccine is on display at the Nikolai Gamaleya National Center of Epidemiology and Microbiology in Moscow, Russia. File/AP
The World Health Organization’s Europe office said it has begun discussions with Russia to try to obtain more information about the experimental COVID-19 vaccine the country recently approved.
Last week, Russia became the first country in the world to license a coronavirus vaccine when President Vladimir Putin announced its approval. But the vaccine has not yet passed the advanced trials normally required to prove it works before being licensed, a major breach of scientific protocol. Russian officials claimed the vaccine would provide lasting immunity to COVID-19 but offered no proof.
Catherine Smallwood, a senior emergency official at WHO Europe said the agency had begun "direct discussions” with Russia and that WHO officials have been sharing "the various steps and information that’s going to be required for WHO to take assessments.”
WHO’s Europe director Dr. Hans Kluge said the agency welcomed all advances in vaccine development but that every vaccine must submit to the same clinical trials.
Russia’s vaccine has so far only been tested in a few dozen people.
Kluge noted that Russia has a long history of developing and administering vaccines, including those for yellow fever and polio.
"This concern that we have around safety and efficacy is not specifically for the Russia vaccine, it’s for all of the vaccines under development,” said Smallwood. She acknowledged WHO was taking an "accelerated approach” to try to speed development of coronavirus vaccines but said "it’s essential we don’t cut corners in safety or efficacy.”
"We’re not going through a rushed job of trying to jump to conclusions here,” Smallwood said. "We want to take our time to really understand where the vaccine’s at and to get as full information as possible on the steps that have already been taken.”
Scientists say advanced trials testing an experimental vaccine in tens of thousands of people is the only way to determine whether or not it works. Two other potential COVID-19 vaccine candidates have already started such studies in the U.S. and elsewhere, and will require about 30,000 people to receive the immunization and be tracked afterward.
Russian officials said doctors might start getting vaccinated with their experimental shot this month and that mass campaigns could begin in October.Associated Press
The World Health Organization said any WHO stamp of approval on a COVID-19 vaccine candidate would require a rigorous safety data review, after Russia announced Tuesday it had approved a vaccine.
Russia has said the vaccine, developed by Moscow's Gamaleya Institute and the first for the coronavirus to go into production, will be rolled out by the end of this month. Some scientists said they fear Moscow may be putting national prestige before safety.
In some good news for millions living in hope for a Covid-19 vaccine shot, the Russian Health Ministry said on Tuesday that the first batch of Sputnik V vaccine has been produced for civilian circulation.
The speed at which Russia is moving to roll out its vaccine highlights its determination to win the global race for an effective product, but has stirred concerns that it may be putting national prestige before sound science and safety.
In a series of tweets, Mahathir said he believed in freedom of expression but that it should not be used to insult others.
In a horrific incident, at least three people have been killed – including one woman who was decapitated — following a knife attack at a church in Nice in southern France.
China will increase the incomes of low-income groups and expand middle class over the 2021-2025 period, Ning Jizhe, the vice head of the National Development and Reform Commission, said at a news conference in Beijing on Friday.